https://www.selleckchem.com/pr....oducts/mitoquinone-m
4%, 79.0%; open, 85.1%, 73.6%; respectively, P=0.04). Overall survival in VATS was not different from open (P=0.58). Propensity matched disease-free and overall survival was not significantly different between two groups. Multivariate Cox regression analysis showed that age [P=0.04, 95% confidence interval (CI) (1.02-6.81)] in overall and T factor [P=0.01, 95% CI (1.41-17.3)] in disease-free survival was prognostic significant after propensity matching. Our study demonstrated that long-term outcome in VATS for early stage a
Like
Comment
Share